£107.98

Springer Health Services for Cancer Survivors: Practice, Policy and Research

Price data checked 1 day ago

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

This is the most expensive it has ever been. Walk away.

£108 today · previous high £108 · all-time low £107

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey
↓ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 90 days • 90 data points

Historical
Generating forecast...
£107.98 £107.20 £107.37 £107.54 £107.71 £107.88 £108.05 18 February 2026 12 March 2026 03 April 2026 25 April 2026 18 May 2026

Price Distribution

Price distribution over 90 days • 2 price levels

Days at Price
Current Price
69 days 21 days · current 0 17 35 52 69 £107 £108 Days at Price

Price Analysis

Most common price: £107 (69 days, 76.7%)

Price range: £107 - £108

Price levels: 2 different prices over 90 days

Description

Health has been conceptualized by world and national health organizations (WHO, CDC, Healthy People 2010) as more than the absence of disease. It involves a focus on physical, psychosocial, and functional aspects of life as well as the prevention of future illnesses. At this point in the development of quality health care for cancer survivors, there is sufficient knowledge and expert opinion to push efforts forward to improve the health of cancer survivors. Clearly there is more research in the most prevalent forms of cancers (e.g., breast cancer) than others that provide us with guidance on how to optimize their health, but there are data on other forms of cancers that can also better inform practice. There may also be general care practices that can cut across cancer types. There has been an emergence of epidemiological and clinical research in cancer survivors that can form the basis for a revolution in the quality and nature of health care that survivors receive. This book not only provides the reader with diverse perspectives and data but also integrates this information so it can serve as the foundation necessary to improve and maintain the health of cancer survivors. Reporting of symptoms to health care providers is a complex, multi-determined problem influenced not only by the pathophysiology but also, as we have learned over the years through pain research, by societal, cultural, and biobehavioral factors. This book will consider this important aspect of follow-up for millions of cancer survivors because of the strong reliance on symptom reporting for clinical decision making. In order for us to generate meaningful and effective treatment, we need to better understand the symptom experience in cancer survivors. This book provides much information that will assist us to better understand and manage this complicated end point. The presenting problems need to be articulated and “conceptualized” as clearly as possible by both parties soappropriate actions can be taken. Since health care costs are a major concern for patients, payers, and providers, this area will also be addressed in all the relevant sections. In taking an interdisciplinary perspective, this book illustrates the importance of a team approach to the improvement of health care and associated health, well-being, and functioning in cancer survivors. The 17 chapters cover critical topics of which physicians and providers of all types must be aware in order to provide the most comprehensive and responsive care for cancer survivors. All of the clinical care chapters include case studies to illustrate the real-world application of these approaches in cancer survivors. Information about sources of referral both within and outside the traditional health care communities will be provided in tabular form. There is no other text that provides both an overview of the problems and their challenges, case illustrations of direct application, and the reality of reimbursement for such care. The editors hope that there may be no need for the clinician or the survivor to adapt to a “new normal” if the presenting problems are understood and handled from an interdisciplinary perspective as outlined here.

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
02 September 2014
Listed Since
27 September 2014

Barcode

No barcode data available

Similar Products You Might Like

Advances in Cancer Survivorship Management (MD Anderson Cancer Care Series)
85% match

Advances in Cancer Survivorship Management (MD Anderson Cancer Care Series)

Springer

£66.52 17 May 2026
Survivors of Childhood and Adolescent Cancer: A Multidisciplinary Approach (Pediatric Oncology)
85% match

Survivors of Childhood and Adolescent Cancer: A Multidisciplinary Approach (Pediatric Oncology)

Springer

£104.18 17 May 2026
The Cancer Patient and Supportive Care: Medical, Surgical, and Human Issues: 25 (Cancer Treatment and Research, 25)
84% match

The Cancer Patient and Supportive Care: Medical, Surgical, and Human Issues: 25 (Cancer Treatment and Research, 25)

Springer

£113.77 18 May 2026
Alternative and Complementary Therapies for Cancer: Integrative Approaches and Discovery of Conventional Drugs
84% match

Alternative and Complementary Therapies for Cancer: Integrative Approaches and Discovery of Conventional Drugs

Springer

£77.90 18 May 2026
AFTER CANCER ISSUES CHANGES MAKING: Issues, Changes, Making a Difference (Cancer Etiology, Diagnosis and Treatments)
83% match

AFTER CANCER ISSUES CHANGES MAKING: Issues, Changes, Making a Difference (Cancer Etiology, Diagnosis and Treatments)

£23.45 11 May 2026
Surviving After Cancer: Living the New Normal
83% match

Surviving After Cancer: Living the New Normal

Rowman & Littlefield Publishers

£27.90 04 May 2026
Improving Outcomes for Breast Cancer Survivors: Perspectives on Research Challenges and Opportunities: 862 (Advances in Experimental Medicine and Biology, 862)
83% match

Improving Outcomes for Breast Cancer Survivors: Perspectives on Research Challenges and Opportunities: 862 (Advances in Experimental Medicine and Biology, 862)

Springer

£78.95 18 May 2026
Nutraceuticals and Cancer
83% match

Nutraceuticals and Cancer

Springer

£113.76 18 May 2026
Palliative Care for Chronic Cancer Patients in the Community: Global Approaches and Future Applications
83% match

Palliative Care for Chronic Cancer Patients in the Community: Global Approaches and Future Applications

Springer

£89.04 04 May 2026
Cancer Clinical Trials: Proactive Strategies: 132 (Cancer Treatment and Research, 132)
82% match

Cancer Clinical Trials: Proactive Strategies: 132 (Cancer Treatment and Research, 132)

Springer

£107.98 18 May 2026
Reproductive Health and Cancer in Adolescents and Young Adults: 732 (Advances in Experimental Medicine and Biology, 732)
82% match

Reproductive Health and Cancer in Adolescents and Young Adults: 732 (Advances in Experimental Medicine and Biology, 732)

Springer

£106.90 18 May 2026
Oncologic Therapies
82% match

Oncologic Therapies

Springer

£81.58 18 May 2026
A Practical Guide to Breast Cancer Treatment
81% match

A Practical Guide to Breast Cancer Treatment

Springer

£103.00 10 May 2026
Systems Biology in Cancer Research and Drug Discovery
81% match

Systems Biology in Cancer Research and Drug Discovery

Springer

£107.98 11 May 2026
Biostatistical Applications in Cancer Research: 113 (Cancer Treatment and Research, 113)
81% match

Biostatistical Applications in Cancer Research: 113 (Cancer Treatment and Research, 113)

Springer

£141.56 18 May 2026
The Voice of Breast Cancer in Medicine and Bioethics: 88 (Philosophy and Medicine, 88)
81% match

The Voice of Breast Cancer in Medicine and Bioethics: 88 (Philosophy and Medicine, 88)

Springer

£113.76 11 May 2026
Metabolism in Cancer: 207 (Recent Results in Cancer Research, 207)
81% match

Metabolism in Cancer: 207 (Recent Results in Cancer Research, 207)

Springer

£73.10 18 May 2026
A Theory of Cancer Care in Healthcare Settings (Routledge Research in Nursing and Midwifery)
81% match

A Theory of Cancer Care in Healthcare Settings (Routledge Research in Nursing and Midwifery)

Routledge

£43.90 18 May 2026
Molecular Oncology: Underlying Mechanisms and Translational Advancements
81% match

Molecular Oncology: Underlying Mechanisms and Translational Advancements

Springer

£80.64 17 May 2026
Cancer Genetics and Therapeutics: Focus on Phytochemicals
81% match

Cancer Genetics and Therapeutics: Focus on Phytochemicals

Springer

£74.27 18 May 2026
Soft Tissue Sarcomas: New Developments in the Multidisciplinary Approach to Treatment: 56 (Cancer Treatment and Research, 56)
80% match

Soft Tissue Sarcomas: New Developments in the Multidisciplinary Approach to Treatment: 56 (Cancer Treatment and Research, 56)

Springer

£148.53 18 May 2026
Drug Resistance in Cancer Therapy: 48 (Cancer Treatment and Research, 48)
80% match

Drug Resistance in Cancer Therapy: 48 (Cancer Treatment and Research, 48)

Springer

£113.76 18 May 2026
MicroRNAs in Cancer Translational Research
80% match

MicroRNAs in Cancer Translational Research

Springer

£129.92 10 May 2026
Lung Cancer Metastasis: Novel Biological Mechanisms and Impact on Clinical Practice
80% match

Lung Cancer Metastasis: Novel Biological Mechanisms and Impact on Clinical Practice

Springer

£80.64 18 May 2026